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Abstract
Proteasomes recognize and degrade poly-ubiquitinylated proteins. In infectious disease, cells activated by interferons (IFNs)
express three unique catalytic subunits b1i/LMP2, b2i/MECL-1 and b5i/LMP7 forming an alternative proteasome isoform, the
immunoproteasome (IP). The in vivo function of IPs in pathogen-induced inflammation is still a matter of controversy. IPs
were mainly associated with MHC class I antigen processing. However, recent findings pointed to a more general function of
IPs in response to cytokine stress. Here, we report on the role of IPs in acute coxsackievirus B3 (CVB3) myocarditis reflecting
one of the most common viral disease entities among young people. Despite identical viral load in both control and IP-
deficient mice, IP-deficiency was associated with severe acute heart muscle injury reflected by large foci of inflammatory
lesions and severe myocardial tissue damage. Exacerbation of acute heart muscle injury in this host was ascribed to
disequilibrium in protein homeostasis in viral heart disease as indicated by the detection of increased proteotoxic stress in
cytokine-challenged cardiomyocytes and inflammatory cells from IP-deficient mice. In fact, due to IP-dependent removal of
poly-ubiquitinylated protein aggregates in the injured myocardium IPs protected CVB3-challenged mice from oxidant-
protein damage. Impaired NFkB activation in IP-deficient cardiomyocytes and inflammatory cells and proteotoxic stress in
combination with severe inflammation in CVB3-challenged hearts from IP-deficient mice potentiated apoptotic cell death in
this host, thus exacerbating acute tissue damage. Adoptive T cell transfer studies in IP-deficient mice are in agreement with
data pointing towards an effective CD8 T cell immune. This study therefore demonstrates that IP formation primarily
protects the target organ of CVB3 infection from excessive inflammatory tissue damage in a virus-induced proinflammatory
cytokine milieu.
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Introduction
Unfolded or misfolded proteins are potentially harmful to cells
and have to be efficiently eliminated before they intoxicate the
intracellular environment. This is of particular importance during
proteotoxic stress as a consequence of intrinsic or extrinsic factors
when the levels of misfolded proteins are transiently or
persistently elevated (Dantuma, 2010 #1). In viral infection
cytokine exposure and inflammation induce the generation of
reactive oxygen species in both immune and non-immune cells
[1,2] with concomitant oxidant-protein damage and proteotoxic
stress. An important defence mechanism is the specific destruc-
tion of these proteins by the ubiquitin-proteasome system (UPS)
[3]. The UPS is among others involved in the regulation of
protein quality control in cardiovascular pathologies [4–6], in
neurodegenerative disorders and other human pathologies [7,8].
The UPS with the 26S proteasome as central proteolytic unit
represents the major ATP-dependent degradation system in
eukaryotes responsible for the maintenance of protein homeo-
stasis and the generation of the vast majority of antigenic peptides
that are presented by MHC class I molecules to CD8
+ Tc e l l si n
infectious disease [9]. Short-lived regulatory proteins involved in
cell differentiation, cell-cycle regulation, transcriptional regula-
tion, or apoptosis, but also aberrant proteins are directed to
proteasomal degradation through conjugation with the small
protein modifier ubiquitin via a cascade of E1, E2, and E3
enzymes, thus forming poly-ubiquitinylated (poly-ub) proteins
[10]. Poly-ub proteins are substrates for 26S proteasomes which
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complexes with the catalytic core complex, the 20S proteasome,
that hydrolyzes proteins into shorter peptide fragments [11,12].
Peptide hydrolyzing activity of the 20S core is restricted to three
b-subunits, i.e. b1, b2, and b5, located in the two inner
heptameric b-rings of the 20S proteasome [13].
Upon interferon (IFN)-exposure of cells or tissues, alternative
catalytically active b subunits, i.e. b1i/LMP2, b2i/MECL-1, and
b5i/LMP7, are induced. These so called immunosubunits are
incorporated into newly formed 20S immunoproteasomes (IP) in
a process that is driven by b5i/LMP7 [14]. b1i/LMP2 and b5i/
LMP7 are encoded within the major histocompatibility II region
and their incorporation into IPs induces altered proteolytic
characteristics that result in many cases in more efficient
liberation of MHC class I epitopes [15–17] particularly within
the early phase of antiviral immunity [18,19]. This increase in
MHC class I peptide supply by IPs appears to be important for
triggering an effective early CD8 T cell response [20–23].
However, controversial findings about the association between IP
function and CD8 T cell priming raised some doubts with regard
to the in vivo impact of these data. In fact, an alternative
physiological function of IPs has been demonstrated recently by
our group in that IPs protect cells against cytokine induced
oxidative damage, thus preserving protein homeostasis. Substrate
modification of oxidant-damaged proteins with poly-ubiquitin
results in protein degradation particularly by IPs [24]. Never-
theless, conclusive studies investigating the role of IP in response
to viral infection beyond the analysis of specific T cell immunity
have not been performed. Also, the importance of this regulated
protease in cardiac disease remains to be elucidated. Within the
context of the murine model of ongoing coxsackievirus B3
(CVB3)-myocarditis, we recently reported on cardiac IP forma-
tion early upon infection in mice being resistant to chronic
disease. The remarkably delayed induction of cardiac IPs in
susceptible mice pointed towards a potential disease-modifying
effect of this finding [19].
Here, we show that cardiac IP prevent exacerbation of acute
CVB3-induced myocardial destruction and possess a protective
function in viral heart disease expanding their role to the
protection of cells against inflammation induced toxic effects
thereby stabilizing cell viability in viral infection.
Results
Characterization of cardiac 20S proteasomes in
CVB3-myocarditis
One well-established model to study myocardial inflammation is
the induction of murine myocarditis with coxsackievirus B3
(CVB3) in C57BL/6 mice leading to acute heart muscle injury
at d8 p.i. [19]. Here, we have challenged both b5i/LMP7
+/+ and
b5i/LMP7
-/- mice on a C57BL/6 background with CVB3.
Cardiac 20S proteasomes isolated from naive mice contain only
very small amounts of b1i/LMP2, b5i/LMP7 and b2i/MECL-1
[19,25]. To test whether b5i/LMP7 deficiency was indeed
sufficient to negatively affect the incorporation of all three
inducible catalytic subunits into cardiac IP in vivo, heart 20S
proteasomes were isolated from naive mice and from CVB3-
infected mice at the early stage of disease (d4 p.i.) and at the acute
stage of myocarditis (d8 p.i.) from both b5i/LMP7
+/+ and b5i/
LMP7
-/- mice. Whereas mRNA expression of b1i/LMP2 and
b2i/MECL-1 was induced in both hosts (Fig. 1A), immunoblot
analysis revealed strongly impaired incorporation of both b1i/
LMP2 and b2i/MECL-1 into cardiac 20S proteasomes in acute
myocarditis in b5i/LMP7
-/- mice (Fig. 1B). Likewise, cytokine
stimulation of primary cardiomyocytes from IP-competent mice
with IFN-c resulted in the efficient induction of all three IP
subunits, whereas as expected incorporation of b1i/LMP2, b2i/
MECL-1 and b5i/LMP7 was impaired in cardiomyocytes isolated
from IP-deficient mice (Fig. 1C).
To obtain quantitative information on the content of each
proteasome subunit within the 20S core complex in vivo, 20S
proteasomes were subjected to reverse phase nano HPLC and
LTQ-Orbitrap mass spectrometry (MS) analysis. All three
inducible subunits b1i/LMP2 (3.5-fold induction; p,0.05), b2i/
MECL-1 (2.6-fold induction; p,0.05) and b5i/LMP7 (2.0-fold
induction; p=0.10) were enhanced in CVB3-challenged hearts as
early as at d4 p.i. in b5i/LMP7
+/+ mice. In contrast, no improved
incorporation of either b1i/LMP2 (1.3-fold; p=0.67) or b2i/
MECL-1 (1.5-fold; p=0.38) was observed in cardiac 20S
proteasomes from b5i/LMP7
-/- mice at this stage of disease.
Table 1 indicates relative quantitative expression levels of all three
inducible subunits in cardiac proteasomes in wildtype mice with
respect to IP-deficient mice. No significant differences were
detected in the content of constitutive proteasome subunits as
exemplarily shown in Table 1 for catalytic subunits b1, b2, and b5,
and for constitutive non-catalytic subunits a2 and b4, respectively.
Notably, in agreement with previous studies [26], b5i/LMP7
-/-
mice show baseline deficits in cardiac b2i/MECL-1 incorporation
being aggravated during inflammation (Table 1). Therefore, b5i/
LMP7
-/- mice encounter a substantial impairment of IP assembly
in inflammation-challenged hearts. This appears to be crucial for
the interpretation of our data in terms of IP deficiency showing a
severe impairment in the incorporation of all three inducible
subunits in acute disease in vivo.
Exacerbation of CVB3-myocarditis in IP-deficient mice
Histological analysis of acute myocarditis was done as previously
published [27] defining acute myocarditis by lymphocytic
infiltrates in association with myocyte necrosis, which we also
see in patients with acute myocarditis [28]. CVB3-myocarditis was
evaluated in IP-deficient mice at early stages of heart muscle
infection (d4 p.i.) and at acute stages of myocarditis (d8 p.i.).
Except for some scattered macrophages, no foci of inflammatory
infiltrates were observed in the myocardium of both mouse strains
at d4 p.i. (Fig. 2B). At this time point severe inflammation of the
pancreas, the primary organ of viral replication, was observed in
Author Summary
The proteasome recognizes and degrades protein sub-
strates tagged with poly-ubiquitin chains. Immune cells
and cells activated by inflammatory cytokines/interferons
express immunoproteasomes (IPs) that are characterized
by unique catalytic subunits with increased substrate
turnover. In infectious disease, the function of IPs is still a
matter of controversial debate. Here, we report on a novel
innate function of IPs in viral infection. We studied the
murine model of acute enterovirus myocarditis, which
represents one of the most common viral disease entities
among young people. We found that IPs protect the
pathogen-challenged tissue from severe injury, which was
reflected in severe myocardial destruction and large
inflammatory foci in mice lacking IPs. We show data that
this prevention of excessive inflammatory tissue damage
in viral heart disease is primarily attributed to preservation
of protein homeostasis due to accelerated substrate
turnover by IPs. Thus, a major innate function of IPs in
viral infection is to stabilize cell viability in inflammatory
tissue injury.
Severe CVB3 Myocarditis in IP-Deficient Mice
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+/+ and b5i/LMP7
-/- mice (Fig. 2A). Pointing
towards accelerated organ destruction in b5i/LMP7
-/- mice,
representative images of the pancreas at d8 p.i. illustrate final
pancreatic islet destruction with fibrous and fatty tissue organ
replacement in b5i/LMP7
-/- mice, with necrotic cells and massive
inflammation still being present in b5i/LMP7
+/+ mice (Fig. 2A).
Clinically, myocardial tissue damage in CVB3-infection is utmost
important since acute myocardial injury may result in severe acute
arrhythmia and heart failure. Focussing on myocardial damage
comprising cardiac cell necrosis and inflammation in acute
myocarditis, IP-deficiency was found to be associated with severe
acute myocarditis. As representatively depicted in Fig. 2B and 2C
for independent experiments by HE staining, at the acute stage of
disease large foci encompassing inflammatory cells and cardiomy-
ocyte necrosis were detected in b5i/LMP7
-/- mice, which is in
striking contrast to small areas of myocardial inflammation and
tissues damage in b5i/LMP7
+/+ mice. To obtain quantitative
information on heart muscle injury, myocarditis scores were
determined yielding a score of 3.160.3 in b5i/LMP7
-/- mice vs.
2.260.2 in b5i/LMP7
+/+ mice (p,0.05, Fig. 2C).
Macrophages and CD3
+ T lymphocytes represent the major
fraction of invading inflammatory cells in acute CVB3-myocarditis
in mice [27,29]. To addressthe inflammatoryinfiltrateinour model
in detail, CD3
+ T lymphocytes, B220
+ B lymphocytes and Mac-3
+
macrophages were studied by immunohistology. As demonstrated
in Fig. 3, the inflammatory infiltrate was primarily comprised of
Mac-3
+macrophagesand toa lesserextentofCD3
+T lymphocytes.
B cells were scattered throughout the inflammatory lesions without
significantly contributing to the invading cellular infiltrate. In
agreement with myocarditis scores (Fig. 2C), quantification of
invading cells revealed significantly increased macrophages and T
lymphocytes in CVB3-infected b5i/LMP7
-/- mice (Fig. 3D). As
suggested by quantitative mRNA expression of CD8 and CD4
molecules in the infected myocardium, both CD4
+ and CD8
+ T
lymphocytes were increased in CVB3-infected b5i/LMP7
-/- mice
(mRNA expression of CD3 revealed the same result, data not
Figure 1. Characterization of 20S proteasomes in IP-deficient mice in CVB3-myocarditis. (A) Quantitative real-time PCR: b1i/LMP2, b2i/
MECL-1, and b5i/LMP7 mRNA expression in the hearts of b5i/LMP7
+/+ and b5i/LMP7
-/- mice at d4 and d8 p.i. Data shown are representative means of
n=5 mice6SEM. (B) 20S proteasomes were isolated from cardiac tissue and subjected to SDS-PAGE followed by immunoblotting (proteasome
subunit a6 is a loading control). Silver staining of isolated 20S proteasomes illustrates equal loading. Data shown are representative for two different
20S proteasome purifications (n=10 mice per experiment). (C) Primary embryonic cardiomyocytes were stimulated with 100 U/ml IFN-c for indicated
time points and the expression of 20S proteasome immunosubunits was determined in whole tissue homogenates. b1i/LMP2 antibody shows a
cross-reaction to constitutive b1 subunit. GAPDH illustrates equal protein loading.
doi:10.1371/journal.ppat.1002233.g001
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natural killer (NK) cells, did not differ in both hosts suggesting
invasion of NK cells in both hosts to the same extent (Fig. 3E). In
summary, immunohistological characterization of myocardial
inflammation revealed that cardiac IP formation protected CVB3-
challenged hearts from exacerbation of acute heart muscle injury.
The presence of infected cardiomyocytes adjacent to foci of
mononuclear cell infiltrates is pathognomonic in viral myocarditis.
Indeed, CVB3 in situ hybridization-positive cardiomyocytes were
found within inflammatory lesions in acute heart muscle injury in
both b5i/LMP7
+/+ and b5i/LMP7
-/- mice (Fig. 4A). However,
despite the severity of myocardial tissue damage in CVB3-
challenged b5i/LMP7
-/- mice, scoring of CVB3 in situ hybridiza-
tion-positive cardiomyocytes pointed towards equal viral replica-
tion in both hosts. Also, the titers of cardiac infectious viral
particles were found to be within the same range in both b5i/
LMP7
+/+ and b5i/LMP7
-/- mice in acute disease (Fig. 4B). To
further investigate viral replication within the context of IP-
deficiency, primary cardiomyocytes from b5i/LMP7
+/+ and b5i/
LMP7
-/- mice were infected with CVB3 in vitro and CVB3
replication was determined by quantitative real-time PCR. These
experiments were also carried out in the presence of type I IFN-
stimulation to mimic the in vivo cytokine milieu in acute heart
muscle injury. As shown in Fig. 4C, IP-deficiency revealed no
influence on CVB3 replication in vitro.
In line with the finding of identical viral load in CVB3-
challenged cardiomyocytes from b5i/LMP7
+/+ and b5i/LMP7
-/-
mice, efficient virus elimination was observed at the chronic stage
of disease at d28 p.i. revealing no relevant signs of ongoing disease
in both hosts (data not shown). These findings pointed towards
efficient induction of both innate and adaptive immunity also in
mice lacking IP. To address this issue in detail, cytokine responses
were determined in acute heart muscle injury (Fig. 5A). Our data
demonstrate increased cardiac expression of pro-inflammatory
cytokines as shown here exemplarily for TNF-a, IFN-b, IL-6 and
IFN-c in acute myocarditis in both b5i/LMP7
+/+ and b5i/
LMP7
-/- mice. Also, the expression of type I IFN-induced antiviral
pathways like the 29 59-oligoadenylate synthetase-like protein-2
(OASL-2), the IFN-stimulated gene 15 (ISG15), the Myxovirus
resistance protein (Mx) and the protein kinase K (PKR) pathway
was efficiently induced in CVB3-challenged hearts from b5i/
LMP7
-/- mice (Fig. 5A).
To determine whether IP expression is required for maintaining
homeostatic levels of B and T cells, we counted B220
+/CD19
+ B
cells and CD4
+ and CD8
+ T cells in spleens isolated from b5i/
LMP7
+/+ and b5i/LMP7
-/- mice. Hensley et al. recently reported
on different absolute B cell and T cell numbers and impairment in
humoral immunity in b1i/LMP2-deficient mice [30]. Here, we
detected equal CD4
+ T cell and B cell numbers in both CVB3-
challenged b5i/LMP7
+/+ and b5i/LMP7
-/- mice (Fig. 5B, C). To
further test humoral immunity in b5i/LMP7
-/- mice, anti CVB3
IgG titers were determined at different time points p.i. CVB3-
antibody titers in b5i/LMP7
-/- mice were found to be within the
range of anti CVB3 IgG in respective wildtype controls (Fig. 5B).
In accordance with data by Fehling et al. [21], CD4
+ and CD8
+ T
cells were not affected by b5i/LMP7 deletion in naive mice
(Fig. 5C). We observed an overall decrease in splenic T cell levels
early upon disease potentially reflecting migration of these cells to
secondary lymphoid organs and to the target organ of infection;
however, host-specific effects were precluded. Also, we did not
observe any differences in the absolute number of splenocytes in
both hosts in acute myocarditis.
Sinceb5i/LMP7-deficiencyhasbeenattributedtoimpairedCD8
T cell responses [21,31], we also investigated CD8 T cell
populations from both b5i/LMP7
+/+ and b5i/LMP7
-/- mice in
vivo. Despite the fact that absolute frequencies of CVB3 VP2 [285–
293]-specific CD8 T cells were rather low, no remarkable
differences were detected in the absolute VP2 [285–293]-peptide
specific CD8 T cell numbers in CVB3-infected b5i/LMP7
+/+ and
b5i/LMP7
-/- mice (Fig. S2A). Given that CD8 T cells are crucial in
the control of CVB3-myocarditis [29,32], absolute CD8 T cell
numbers for CVB3 epitopes are low and detection of specific CD8
T cell frequencies is limited inthis infection model, adoptivetransfer
studies of CVB3-memory CD8 T cells from IP-deficient and IP-
competent mice appeared to be the most reliable approach to
address the effect of IP-deficiency on CD8 T cell function. Take of
donor CD8 T cells from CVB3-infected mice is shown in Fig. S2B.
To preclude effects of IP-deficiency on CD8 T cell survival, CD8 T
cells were isolated from CVB3-challenged b5i/LMP7
+/+ and b5i/
LMP7
-/- mice (both CD45.2) at d8 p.i. and transferred into naive
B6.SJL-Ptprca Pepcb/BoyJ mice (CD45.1). The amount of
transferred CD8 T cells was assessed at d8 after adoptive T cell
transfer revealing no impairment of IP-deficiency on CD8 T cell
survival (data not shown). Also, transfer of b5i/LMP7-deficient
CD8 T cells (CD45.2) into CVB3-infected B6.SJL-Ptprca Pepcb/
BoyJmice (CD45.1) andvice versarevealed comparable CD8T cell
survival rates (Fig. 5D left panel). Next, CD8 T cells were isolated
from CVB3-infected b5i/LMP7
+/+ and b5i/LMP7
-/- mice (both
CD45.2) at d8 p.i. These cells were transferred into naive b5i/
LMP7
+/+ and b5i/LMP7
-/- mice, which were then infected with
CVB3 and sacrificed at d8 p.i. to assess myocarditis scores.
Following adoptive T cell transfer of IP-deficient CD8 T cells into
either IP-deficient or IP-competent recipients, we observed no effect
on acute heart muscle inflammation in comparison to adoptive T
cell transfer of CD8 T cells from IP-competent mice into both
recipients (Fig. 5D right panel). Of note, adoptive T cell transfer of
CD8 T cells from either CVB3-infected b5i/LMP7
+/+ and b5i/
LMP7
-/- mice into b5i/LMP7
-/- recipient mice resulted in a slightly
milder acute disease than in non-transfected mice (respective
myocarditis score from CVB3-infected donor mice are shown in the
Table 1. Quantification of proteasome subunits by mass
spectroscopy in IP-deficient mice.
b5i/LMP7
+/+/
b5i/LMP7
-/- Control d4 p.i. d8 p.i.
Ratio p-value Ratio p-value Ratio p-value
a2 1.18 0.51 1.01 0.99 1.03 0.93
b4 1.17 0.51 1.06 0.84 1.12 0.68
b1 1.19 0.48 1.18 0.63 1.10 0.72
b2 1.37 0.29 1.27 0.50 1.08 0.77
b5 1.12 0.71 0.96 0.91 0.76 0.41
b5i/LMP7 n.d. n.d. n.d.
b1i/LMP2 1.32 0.48 3.70 0.04 1.82 0.18
b2i/MECL1 5.25 0.01 9.18 ,0.001 2.64 ,0.001
20S proteasomes were isolated from murine hearts from control mice and at
day 4 and 8 p.i. from b5i/LMP7
+/+ and b5i/LMP7
-/- mice. The mixture of tryptic
20S proteasome peptides was separated prior to mass spectrometric analysis by
reverse phase nano HPLC using a Proxeon System; MS-data were generated on
an Orbitrap-MS equipped with a nanoelectrospray ion source as described in
material and methods. MS ion intensities are shown for individual proteasome
subunits as ratios between b5i/LMP7
+/+ and b5i/LMP7
-/- mice. Data are
mean6SD from two technical replicates that have been performed each with
two independent biological replicates. p,0.05 indicates statistical significance.
n.d.: ratio was not determined for b5i/LMP7.
doi:10.1371/journal.ppat.1002233.t001
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cell transfer of both b5i/LMP7
-/- and b5i/LMP7
+/+ T cells, thus
arguing against a detrimental effect of IP-deficiency on memory
CD8 T cell function and being in accordance with the observation
of equal virus titers and efficient viral clearance in both b5i/
LMP7
+/+ and b5i/LMP7
-/- mice.
IP-deficient hearts are prone to oxidant protein damage
and accumulation of poly-ub conjugates
The data above illustrated severe tissue damage in CVB3-
challenged hearts in mice lacking IPs and revealed large foci of
i n f l a m m a t o r yl e s i o n si nt h i sh o s t .G i v e nt h a tI P sp r e s e r v e
protein homeostasis and cell viability in response to cytokine
stress [24], one may argue that viral infection induced cytokine
release affects the cellular protein equilibrium in cardiomyo-
cytes and invading inflammatory cells, which may further
exacerbate heart muscle injury in IP-deficient hearts. To test
this hypothesis, primary cardiomyocytes and B-cell depleted
splenocytes (which represent the major populations of invading
inflammatory cells) were isolated from b5i/LMP7
+/+ and b5i/
LMP7
-/- mice and exposed to IFN-c (cell purity is depicted in
Fig. S1). Upon cytokine exposure, lack of IPs resulted in
Figure 2. Severe acute CVB3-myocarditis in IP-deficient mice. Representative hematoxylin-eosin (HE)-staining are illustrated from (A) the
pancreas and (B) the heart of b5i/LMP7
+/+ and b5i/LMP7
-/- mice at different time points p.i. revealing severe acute myocarditis in b5i/LMP7
-/- mice at
d8 p.i. All cardiac and pancreatic tissue sections shown are representative for at least n=10 mice/group. (C) Tissue sections from a different
experiment confirmed severe heart muscle injury in b5i/LMP7
-/- mice at d8 p.i. (enlarged image). To quantify myocardial damage comprising cardiac
cell necrosis, inflammation, and scarring, a myocarditis score from 0 to 4 was applied (0: no inflammatory infiltrates, 1: small foci of inflammatory cells
between myocytes, 2: larger foci of .100 inflammatory cells, 3: #10% of cross-section involved, 4: 10 to 30% of a cross-section involved) [50]
(* p,0.05; mean from n=5 mice).
doi:10.1371/journal.ppat.1002233.g002
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more detail, immunohistology for (A) Mac-3
+ macrophages, (B) B220
+ B lymphocytes and (C) CD3
+ T lymphocytes were performed. Representative
cardiac tissue sections are shown, immunohistology was performed for at least n=6 mice/group. No specific signals were observed in naive control
mice. (D) Quantification of immunohistochemically positive cells was achieved by counting all positive cells per visual field at a magnification of x200
in transverse heart tissue sections. Arithmetic means from n $5 mice/group6SEM are shown. Differentiation of individual signals for Mac-3 was
limited due to massive macrophage infiltration/staining; thus quantitative data are not reflecting absolute macrophage numbers. (E) Quantitative
real-time PCR: mRNA expression of CD8 for CD8 T cells, CD4 for CD4 T cells and NKP46 for natural killer cells was determined in the hearts of b5i/
LMP7
+/+ and b5i/LMP7
-/- mice at d8 p.i. Data shown are representative means of n=5 mice6SEM, * p,0.05.
doi:10.1371/journal.ppat.1002233.g003
Figure 4. Viral load is not affected in IP-deficient mice. (A) The amount of genomic CVB3 RNA as detected by in situ hybridization was scored
within a range from 0 to 4 for cardiac tissue sections (n=10 mice/group). Representative strand-specific in situ hybridizations for CVB3 RNA (black
dots) in hearts at the acute stage of myocarditis (d8 p.i.) illustrate equal viral load in both hosts. (B) Plaque assays were performed revealing equal
amounts of infectious virus particles in CVB3-infected hearts from b5i/LMP7
+/+ and b5i/LMP7
-/- mice (n.s.). (C) Primary cardiomyocytes from b5i/
LMP7
+/+ and b5i/LMP7
-/- mice were infected with CVB3 MOI 0.1 and 0.5 for 8 h. To mimic in vivo infection, cardiomyocytes were partially cultured
with IFN-b for 24 h prior to CVB3 infection. Viral replication was assessed by quantitative real-time PCR. One representative experiment of three
independent experiments is shown.
doi:10.1371/journal.ppat.1002233.g004
Severe CVB3 Myocarditis in IP-Deficient Mice
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(Fig. 6A). Failure of IP expression also coincided with increased
accumulation of oxidant-damaged proteins in IP-deficient
cardiomyocytes and inflammatory cells in response to pro-
longed cytokine exposure (Fig. 6A). IPs also contribute to the
activation of NFkB transcription factor by accelerated turnover
of IkBa, which is crucial for multiple processes in inflammation
and apoptosis [24,33]. Impaired activation of NFkB as shown
here by reduced levels of NFkB p50 subunits in IP-deficient
cardiomyocytes and inflammatory cells (Fig. 6B) reflected
reduced proteasomal degradation of NFkB p105 precursor
proteins, which is in concordance with impaired proteolysis in
IP-deficient cells as shown in Fig. 6A.
These data suggested a role of IPs in regulating proteotoxic
stress also in the infected myocardium. Indeed, IP-deficient mice
failed to cope with accelerated protein turnover in CVB3 infection
as reflected by increased accumulation of poly-ub proteins in acute
inflammatory viral heart disease (Fig. 6C). The IP-deficient
myocardium was not able to efficiently cope with the required
protein turnover in acute CVB3 myocarditis (Fig. 6D + Fig. S3).
Consequently, we observed significantly enhanced ALIS formation
in the injured myocardium (evaluation of poly-ub-aggregates
Figure 5. Adaptive immune responses in CVB3-infected IP-deficient mice. (A) Quantitative real-time PCR: mRNA expression of indicated
cytokines (first row) and antiviral molecules of the innate immune response (second row) was determined in the hearts of b5i/LMP7
+/+ and b5i/
LMP7
-/- mice at d4 and d8 p.i. Data shown are mean of n$5 mice6SEM. (B)+(C) Flow cytometric analysis was completed on splenocytes isolated from
b5i/LMP7
+/+ and b5i/LMP7
-/- mice at d4 and d8 p.i. (n=6 mice, representative for 3 independent experiments). (B) Cell numbers of B cells (CD19
+,
B220
+) are illustrated as % of each cell population in comparison to the total number of cells from each spleen (left panel). CVB3-specific IgG levels
were determined in sera collected at indicated time points, and titers of virus-specific IgG antibodies were determined by a CVB3-specific ELISA (n$8
mice, right panel). (C) Ratios of CD4
+ T cells (CD4
+, CD3
+) and CD8
+ T cells (CD8
+, CD3
+) are illustrated. (D) For T cell transfer studies splenic CD8 T cells
were separated by MACS (Miltenyi Biotec) from 1610
7 splenocytes (Fig. S2B). Left panel: To assess T cell survival after adoptive transfer, CD8 T cells
were transferred from CVB3-infected b5i/LMP7
+/+ (CD45.1) into b5i/LMP7
-/- (CD45.2) mice and from b5i/LMP7
-/- mice (CD45.2) into b5i/LMP7
+/+ mice
(CD45.1). Recipient mice were infected with CVB3 and sacrificed at d8 p.i. T cell survival was determined in splenocytes by flow cytometry. Middle
panel: Prior to adoptive T cell transfer, b5i/LMP7
+/+ and b5i/LMP7
-/- mice were infected with CVB3 and myocarditis scores were determined at d8 p.i.
(n=5 mice). Right panel: Then, splenic CD8 T cells were isolated from these CVB3-infected mice at d8 p.i. as described above; 1–2610
6 CD8
+ T cells
from one donor were injected i.v. through the tail vein into one recipient. Recipient mice were then infected with CVB3 i.p. and sacrificed at d8 p.i.
Myocardial damage was evaluated in HE staining as described above. Data shown are mean for n=5 mice and are representative for two
independent experiments.
doi:10.1371/journal.ppat.1002233.g005
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+/+ mice: 13.5 ALIS /
1088 mm
261.0 vs. b5i/LMP7
-/- mice: 20.0 ALIS / 1088 mm
26
1.8; p,0.05; n=5 mice). These poly-ubiquitin conjugates were
primarily detected within inflammatory lesions in invading
inflammatory cells, and within the cytoplasm and nuclei of
adjacent cardiomyocytes in acute myocarditis (Fig. 6E). Also, poly-
ub signals were found to be increased in b5i/LMP7
-/- mice in
comparison to b5i/LMP7
+/+ mice at d8 p.i. (Fig. 6E + Fig. S4).
Since oxidant damaged proteins become substrates of the 26S IP
upon tagging by poly-ub [24], the levels of carbonyl groups
reflecting oxidant protein damage were monitored. As illustrated
in Fig. 6F, oxidant protein damage was increased in acutely
inflamed hearts in IP-deficient mice.
IP-deficient hearts are prone to apoptotic cell death
Since CVB3 titers were found to be within the same range in
both hosts (Fig. 4), cytolytic effects of CVB3 do apparently not
explain severe tissue injury as observed here in IP-deficient mice.
However, oxidative-protein damage, inefficient degradation of
poly-ub protein aggregates and reduced activation of NFkB
transcription factor in CVB3-challenged hearts in mice lacking IPs
may affect cell viability. Indeed, cytokine-induced cellular injury
Figure 6. Accumulation of poly-ub protein conjugates in IP-deficient mice. (A) Primary cardiomyocytes and B-cell depleted splenocytes
from b5i/LMP7
+/+ and b5i/LMP7
-/- mice were incubated with IFN-c for indicated time points. Lack of IP formation resulted in accumulation of poly-ub
substrates and of oxidant-damaged proteins (staining of carbonyl groups) upon IFN-c exposure in both cell populations (cell purity is depicted in Fig.
S1). GAPDH illustrates equal protein loading. Images are representative from at least two independent experiments. (B) NFkB p50 levels were
determined in whole cell homogenates from IFN-c (100 U/ml for 24 h) treated primary cardiomyocytes and B-cell depleted splenocytes upon 30 min
TNF-a exposure. Data are shown as fold increase of p50 levels in comparison to untreated control cells (representative mean from triplicates from at
least two independent experiments). (C) Immunoblot of CVB3-infected cardiac homogenates from five individual b5i/LMP7
+/+ and b5i/LMP7
-/- mice
(d8 p.i.) stained for poly-ub-conjugates (from the same transfer; representative for n=10 mice). Densitometry was performed for individual lanes for
these five different mice (normalization to GAPDH control) yielding increased levels of poly-ub signals in b5i/LMP7
-/- mice (mean6SEM). (D)
Formation of poly-ub containing ALIS (white arrowheads) was visualized by immunofluorescence: heart cryosections were stained with FK1 for poly-
ub (green) and Hoechst (blue). Here, slides are representative for n=6 mice from two independent experiments (more data is illustrated in Fig. S3). (E)
To localize poly-ub conjugates within the injured myocardium, immunohistology staining of ubiquitin was performed in control and CVB3-infected
mice (d8 p.i.). Representative tissue sections are shown. For more information see Fig. S4 to this figure. (F) CVB3-challenged cardiac lysates from from
five individual b5i/LMP7
+/+ and b5i/LMP7
-/- mice (d8 p.i.; representative for n=9 mice) stained for oxidant-damaged proteins by staining of carbonyl
groups. Quantitative evaluation of oxy-staining was performed as described above. All statistical data are mean6SEM; * p,0.05 as determined by
Mann-Whitney U test.
doi:10.1371/journal.ppat.1002233.g006
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phages that were isolated from IP-deficient mice (data not shown).
To study cellular injury due to apoptotic cell death in vivo, DNA
strand breaks as an early sign of apoptosis were assessed in cardiac
tissue sections. No apoptotic cell death was detected in hearts from
b5i/LMP7
+/+ and b5i/LMP7
-/- mice at d4 p.i. (Fig. S5).
However, in acute heart muscle injury (d8 p.i.), increased levels
of DNA strand breaks were detected particularly within inflam-
matory lesions and the surrounding tissue in CVB3-challenged
b5i/LMP7
-/- mice (Fig. 7, Fig. S5+S6). TUNEL positive staining
was detected throughout the injured heart in IP-deficient mice;
thus, apoptotic cell death was found to be quantitatively increased
in b5i/LMP7
-/- mice. Despite the fact that minor inflammatory
lesions were also detected in CVB3-infected b5i/LMP7
+/+ mice
(d8 p.i.), here no significant apoptotic cell death occurred (Fig. 7).
This observation is in agreement with previously published data
[29]. These findings support the role of IP formation in
cardiomyocytes and in inflammatory cells to protect the injured
tissue from proteotoxic stress, which may exacerbate acute heart
muscle injury in viral heart disease.
Discussion
Proteasomes are responsible for the generation of peptides
derived from pathogens or cellular proteins that are presented by
MHC class I molecules on the cell surface to cytotoxic T cells
(CTLs) [11]. Despite the fact that in vitro studies argued in favor of
an impact of IP-dependent MHC class I antigen processing [15–
17,19], in vivo studies using IP-deficient mice reported conflicting
data on the induction of CD8 T cell responses [17,21,23,34]. CD8
T cells are crucial in virus elimination in CVB3-myocarditis
[29,32]. To study a potential contribution of IPs to the generation
of CD8 T cell responses in CVB3-myocarditis, here adoptive
memory CD8 T cell transfer experiments were performed since
limited knowledge on immunodominant CVB3-specific CD8 T
cell epitopes restrains solid quantification of CD8 T cell responses
in murine enterovirus myocarditis [19,35]. Transfer of CVB3
memory CD8 T cells from IP-competent mice did not reveal a
beneficial effect on CVB3 myocarditis in comparison to transfer of
CD8 T cells from IP-deficient mice. Likewise, CVB3 titers were
within the same range in IP-deficient and wildtype control mice in
acute myocarditis (Fig. 4) and the virus was efficiently eliminated
in both hosts at d28 p.i. These findings support the induction of
efficient CD8 T cell responses also in CVB3-challenged IP-
deficient mice, which is in agreement with observations in other
infection models: the kinetics of lymphocytic choriomeningitis
virus clearance were similar in both b5i/LMP7
+/+ and b5i/
LMP7
-/- mice [34]. This strongly supports the notion that the key
innate function of IP in enteroviral heart disease lies elsewhere.
Here, we have illustrated that IPs in CVB3-induced heart muscle
injury preserve protein homeostasis and maintain cell viability in
order to protect the inflammation-challenged myocardium from
severe damage.
The UPS adapts to stress induced requirements by increased
substrate turnover exerted by IPs, which possess improved
peptide-hydrolyzing activity [15,17,35], and poly-Ub-substrate
Figure 7. IP-deficient hearts are prone to apoptotic cell death. Apoptosis was assessed in vivo in cardiac tissue sections in naive and CVB3-
challenged mice (d8 p.i.) by in situ cell death detection kit, TMR red. Representative cardiac sections from two independent experiments (infection of
n=5 mice / experiment) are shown. Left panels: controls - upper two slides from first experiment, lower two slides with positive controls from second
experiment illustrating DNA strand breaks in inflammatory lesions and surrounding cardiomyocytes, which colocalize to nuclei (merge with Hoechst
staining). More information is provided in Fig. S5 + 6 to this figure.
doi:10.1371/journal.ppat.1002233.g007
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resulted in enhanced proteasomal peptide-hydrolyzing activity
[19]. One of the pivotal functions of the UPS is to limit the
accumulation of potentially toxic misfolded proteins and protein
aggregate formation, which as consequence of cellular stress
represent a constant threat to normal cell function and cell
viability [7,36]. Also, CVB3-infection [2] as well as cytokine stress
in inflammation [1] induce oxidative stress. Likewise, the
pathogenesis of severe CVB3 myocarditis has been attributed to
increased oxidative stress [37–39]. In agreement with our previous
study reporting on the activity of the 26S IP for efficient
elimination of oxidatively modified, poly-ub proteins in response
to cytokine stress [24], here we demonstrated that IP function in
both residing host cells and invading inflammatory cells is crucial
for the efficient degradation of poly-ub proteins in acute viral heart
disease. Elimination of nascent oxidant-damaged, poly-ub proteins
by the 26S IP prevented the accumulation of harmful protein
aggregates [7,36], which may exacerbate acute heart muscle
injury.
Moreover, as a consequence of impaired IP function, poly-ub
proteins accumulated in ALIS in CVB3-infected hearts. Such
aggregates, which are at least partially comprised of CVB3
proteins [40], are not inert metabolic end products, but may
actively influence the metabolism of cells [41]. As shown here,
degradation of oxidant-damaged, poly-ub proteins by cardiac 26S
IPs in CVB3-challenged hearts resulted in ALIS degradation and
likewise protected cardiomyocytes and invading inflammatory cells
from proteotoxic stress. This first histological demonstration of
severe tissue injury in virus infection in mice lacking IPs is in
agreement with findings in experimental acute encephalomyelitis
(EAE). IPs prevented accumulation of toxic protein aggregates in
EAE, coinciding with less severe disease manifestation in IP-
competent mice [24]. The detection of both poly-ub proteins in
concert with apoptotic cell injury within inflammatory lesions in
viral heart disease (Fig. 6+7) also supports the association between
proteotoxic stress and cellular injury in this model [7,24]. In fact,
cellular injury as shown here by increased apoptotic cell death of
invading inflammatory cells and adjacent cardiomyocytes in IP-
deficient mice may result in the release of endogenous molecules,
which as damage-associated molecular patterns (DAMPs) signal
the threat of infection and injury to the organism. High levels of
DAMPs have been linked to the pathogenesis of many
inflammatory diseases, drive cellular activation and immunoreac-
tivity [42]. This may in fact exacerbate acute inflammation and
also result in killing of non-infected cardiomyocytes. Thus, IPs
prevent excessive proteotoxic stress and cellular injury, which in
consequence may limit additional effects like DAMP-associated
activation of immunopathology.
Remarkably, this is the first study illustrating a detrimental
effect of IP-deficiency in a viral infection-induced phenotype
despite a lack of a significant effect of IPs on pathogen load. Our
findings are in agreement with the observation that absence of
b5i/LMP7 expression impairs the beneficial effects of IFN-b in
patients suffering from multiple sclerosis [43]. In contrast, absence
of IP-function either as a result of b5i/LMP7 deficiency or
inhibition of b5i/LMP7 catalytic activity by PR-957 have recently
been associated with attenuated experimental colitis [44].
Depending on the pathogenesis of the underlying disease, IP
deficiency seems to exert either protective effects or to aggravate
the consequences of inflammation in a disease or tissue-specific
manner. Indeed, cytokine responses in IP-deficient mice differ
considerably and are strikingly dependent on the disease entity
being studied. CVB3 infection of IP-deficient mice revealed a
cytokine induction in viral heart muscle injury comparable to that
observed in wildtype mice (Fig. 5A). In contrast, amelioration of
experimental colitis has been connected to limited induction of
proinflammatory cytokines and chemokines [33,44]. This was
attributed to impaired activation of transcription factor NFkB, a
central regulator of inflammation in inflammatory bowel disease
[33]. In line with impaired NFkB activation in TNF-a stimulated
murine embryonic fibroblasts [33], this study demonstrated
reduced NFkB activation in cytokine-stressed cardiomyocytes
and inflammatory cells lacking IPs (Fig. 6B). This may be
attributed to the fact that IkBa, a specific inhibitor of NFkB
activation, is degraded much faster in cells expressing IPs [45].
Also, IkBa has been identified to be oxidatively-modified upon
cytokine stress, which supports the role of IPs in degradation of this
specific substrate [24]. Whereas increased activation of NFkBi s
believed to exert detrimental functions in immune and non-
immune cells in tissues affected by chronic inflammation, NFkB
inhibition can also be harmful for the organism, and trigger the
development of inflammation and disease. These findings
suggested that NFkB signaling has important functions for the
maintenance of physiological immune homeostasis and for the
prevention of inflammatory diseases [46]. Studies with specific
inhibitors of NFkB nuclear translocation and activity revealed
induction of apoptosis, thus argueing in favor for anti-apoptotic
effects of this prosurvival transcription factor as well [47]. In
agreement with these findings, the here described impaired
activation of NFkB may additionally contribute to the effects of
proteotoxic stress, which resulted in cellular injury as shown in
Fig. 7. Whereas interference with two major pathways leading to
NFkB activation exerts beneficial effects in experimental colitis
and anti-cancer treatment, our data indicate that activation of
NFkB-mediated responses protects cytokine-challenged cardiomy-
ocytes and inflammatory cells and argues against a significant
contribution of NFkB to cytokine induction in viral heart disease.
In conclusion, our findings support the view of a distinct tissue
specific contribution of IP function driven by the pathogenesis of
the underlying inflammatory disease.
Material and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the German animal welfare act, which is
based on the directive of the European parliament and of the
council on the protection of animals used for scientific purposes.
This study conforms to the Berlin State guidelines for animal
welfare. The protocol was approved by the Committee on the
Ethics of Animal Experiments of Berlin State authorities (Permit
Number: G0311/06). All efforts were made to minimize suffering.
Mice
CVB3 (cardiotropic Nancy strain) used in this study was
prepared as previously described [48]. C57BL/6 mice were
initially from Jackson Laboratory. C57BL/6 b5i/LMP7
-/- mice
originally obtained from HJ Fehling [21], who backcrossed them
with C57BL/6 mice 10 times. Breeding pairs were kindly provided
by U Steinhoff (Berlin, Germany). Mice were kept at the animal
facilities of the Charite ´ University Medical Center. Six week-old
mice were infected i.p. with 1610
5 PFU CVB3. Hearts were
perfused with PBS, weighted and quickly frozen in liquid nitrogen
before storage at -80uC. For some lymphocyte transfer experi-
ments, B6.SJL-Ptprca Pepcb/BoyJ were purchased from Jackson
Laboratory.
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Primary cardiomyocytes (CM) were isolated from fetal mouse
hearts (E13). Hearts were incubated in EDTA/Trypsin at 4uC
overnight, followed by 15 min incubation at 37uC. Cardiac cells
were resuspended in standard medium and transferred into cell
culture flasks. Purity was determined by flow cytometry using
cardiomyocyte-specific troponin I antibodies (abcam # 47003).
Inflammatory cells were taken from whole spleen cell suspensions,
which were B cell depleted by MACS (Miltenyi Biotec). All cell lines
were cultivated under standard conditions in Dulbecco’s MEM
(MEFs) each containing 10% fetal calf serum (FCS), 2 mM L-
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells
were treated with either100 U/mlIFN-b, 100 U/mlIFN-c (Sigma-
Aldrich) or 30 ng/ml TNF-a (all Sigma-Aldrich). Cells were infected
with CVB3 (cardiotropic Nancy strain) MOI 0.1 or 0.5 as indicated.
Plaque assay was performed as described previously [19].
In situ hybridization and histological staining
In situ hybridization of genomic CVB3 RNA, histological
staining with hematoxylin / eosin (HE) and immunohistochem-
istry for detection of CD3
+ T lymphocytes and Mac-3
+
macrophages were carried out and analysed as described [27].
Immunohistochemical stainings for ubiquitin and B cells were
performed on a Ventana Benchmark stainer using the Vectostain
Elite ABC Kits (Vector Laboratories; Burlingame, CA). The
following primary antibodies were used: anti-ubiquitin 1:1000
(DAKO Cytomation, Glostrup, Denmark) and CD45R/B220
1:100 (BD Pharmingen, Heidelberg, Germany). Biotin-labeled
secondary antibodies (goat-anti-rabbit and goat-anti-rat) were
purchased from Jackson Immuno Research (Dianova, Hamburg,
Germany) and used at a dilution of 1:100. All slides were
counterstained with hematoxylin.
Immunofluorescence
Processing of cryo-sections and Hoechst staining was performed
as described [24]. Briefly, cryo-sections were fixed in 4%
paraformaldehyde, washed and permeabilized with PBS/1%
TritonX. Staining was performed with FK1 mAb (PW 8805,
Biomol, Germany) at 4uC over night. Confocal images were
acquired on a Leica TCS SP2 microscope (Leica Microsystems).
Quantification of ALIS has been based on counting cells with
accumulation of poly-ub conjugates (focused staining over
background defined as ub-rich inclusions) in defined areas
(1088 mm
2) at 100-fold magnification.
TaqMan quantitative RT-PCR
RNA preparation and cDNA synthesis were performed as
described recently [19]. TaqMan PCR was performed using
primers and probes of TaqMan Gene Expression Assays (Applied
Biosystems, Germany). mRNA expression was normalized to the
housekeeping gene HPRT by means of the DCt method.
Immunoblot analysis
Cell or tissue lyses was performed in 20 mM TRIS-HCl,
pH 7.5, 10 mM EDTA, 100 mM NaCl, 1% NP40, 10 mM
MG132, 5 mM NEM, Complete protease inhibitor cocktail
(Roche, Germany). Immunoblot analysis was performed according
to standard protocols. ubiquitin: Z0458 DAKO; a6 (pc, K379),
b5i/LMP7 (pc, K63), b2i/MECL-1 (pc, K65): lab stock (all
generated against peptides of the respective protein), b1i/LMP2:
Abcam #3328 for isolated proteasomes or b1i/LMP2: lab stock
for cardiomyocytes (cross-reaction with b1, pc, K620/21); a-actin,
GAPDH: Santa Cruz.
Determination of oxidative stress and apoptosis
The detection of oxidatively-damaged proteins was performed
indirectly by chemical derivatization: this derivatization captures
the oxidative state immediately during or after homogenization of
the tissue. Oxidized proteins were visualized with the OxyBlot
protein oxidation detection kit (Chemicon International) via
immunodetection of carbonyl groups. DNA strand breaks
(TUNEL assay) were determined by in situ cell death detection
kit, TMR red (Roche, Germany) or in situ cell death detection kit,
POD (Roche, Germany) according to the instructions of the
manufacturer. POD stained slides were counterstained by
hematoxylin.
NFkB ELISA
After induction of IPs with IFN-c, primary cardiomyocytes and
B-cell depleted splenocytes were stimulated with 30 ng/ml TNF-a
for 30 min. p50 NFkB was determined in whole tissue
homogenates by ELISA according to the manufacture’s instruc-
tions (ActiveMotif, Rixensart, Belgium).
Detection of CVB3-specific antibodies by ELISA
CVB3-specific IgG antibody titers were determined with
Enterovirus ELISA Kit (Genzyme Diagnostics) according to the
manufacture’s instructions [alternative secondary antibody (POX
anti-mouse IgG, Dianova) was used]. CVB3-specific antibody
titers are presented as log2 of the maximum dilution of serum
showing an optical density greater than the mean optical density of
sera obtained from naive mice plus threefold SD as described
recently [27].
Flow cytometry
After Fc-receptor blockade cells were incubated with different
combinations of fluorescently labeled Abs (eBiosciences and BD
Biosciences) and samples were analyzed using CYAN-ADP flow
cytometer (Beckman Coulter, Germany) or BD FACSCalibur
(Becton Dickinson).
Lymphocyte transfer
At day 8 p.i., CVB3-infected mice were sacrificed and
splenocytes were isolated according to standard protocols. CD8
+
T cells were purified by positive selection using commercially
available kits yielding a purity of at least 85% (Miltenyi Biotec). 1-
2610
6 CD8
+ T cells from one donor were injected i.v. through the
tail vein into one recipient. After T cell transfer, mice were injected
i.p. with 1610
5 PFU CVB3 and sacrificed at the acute stage of
infection at d8 p.i. Myocarditis was assessed as described above.
Quantification of proteasome subunits
20S proteasomes were isolated according to standard procedure
as described [19]. The mixture of tryptic peptides was separated
prior to mass spectrometric analyses by reverse phase nano HPLC
on a 15 cm PepMap100-column (3 ml, 100 A ˚) using an Proxeon
System (Odense, Denmark) at a flow rate of 1 ml/min. Separation
was carried out in a linear gradient within 86 min using 0.05%
acetic acid, 2% acetonitrile in water and 0.05% acetic acid in 45%
acetonitrile as eluents. MS-data were generated on an LTQ-
Orbitrap-MS equipped with a nanoelectrospray ion source
(PicoTip Emitter FS360-20-20-CE-20-C12, New Objective). After
a first survey scan (r=60,000) MS2 data were recorded for the five
highest mass peaks in the linear ion trap at a collision induced
energy of 35%. The exclusion time was set to 30 s and the
minimal signal for MS2 was 1,000. Peptide identification was
achieved by searching the SwissProt database rel. 57.1 restricted to
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and further processed by PeptideTeller and ProteinTeller [49]
within the Elucidator system (Rosetta Biosoftware, Seattle, WA,
U.S.A.). ProteinTeller results were further used for annotation,
with a predicted error rate of,5%. Quantitative analysis of label-
free MS data was achieved with the Elucidator system using
peptide intensities as proxies for label-free peptide abundance
measurements. The following criteria for frame and feature
annotation were used: retention time minimum cut-off 9 min,
retention time maximum cut-off 80 min, m/z minimum cut-off
300, instrument mass accuracy 5 ppm, alignment search distance
10 min. For quantitative analysis, the data were normalized and
further grouped (two biological and two technical replicates).
Statistics
Results of continuous variables are expressed as mean6-
standard error of mean (SEM) if not indicated otherwise. Two
group comparisons of non-parametric data were performed using
the Mann-Whitney test. Statistical significance between multiple
groups was determined using two-way ANOVA and post hoc
analysis with a Bonferroni test. Significance was assessed at the
p,0.05 level (* indicates significant differences).
Accession numbers
TNF-a (Q0X0E6,P06804), IFN-b (P01575), IL-6 (P08505),IFN-
c (P01580), OASL-2 (Q9Z2F2), ISG15 (Q64339), Mx (P09922),
PKR (Q03963), NFkB p105 (P25799), IkBa (Q9Z1E3), TLR7
(P58681), TLR8 (P58682), LMP2 (P28076), MECL-1 (O35955),
LMP7 (P28063), CD8 (P01731), CD68 (P31996), CD3 (P22646),
B220 (P06800), CD4 (P06332), CD19 (P25918)
Supporting Information
Figure S1 Characterization of primary cardiomyocytes
and inflammatory cells. (A) Primary cardiomyocytes (CM)
were isolated from fetal mouse hearts. Purity was determined by
flow cytometry using cardiomyocyte-specific troponin I antibodies
revealing .93% troponin I
+ cells. Representative histograms are
shown (unstained cells in upper panels, troponin I / Alexa488-anti
rabbit IgG staining in lower panels). Also, after cell adherence all
visible cells demonstrated spontaneous contraction in cell culture,
thus representing a common hallmark of cardiomyocytes in
addition to specific troponin I expression. (B) Inflammatory cells:
representative histograms illustrate B220
+/CD19
+ B cells from
whole spleen cell suspensions prior to and after B cell depletion by
MACS.
(PDF)
Figure S2 Viral epitope-specific T cell responses in
acute myocarditis and take of CD8 donor T cell for
adoptive transfer experiments. (A) Pentamer staining of VP2
[285–293]-specific CD8 T cells. H-2
b- PE pentamers for virus
capsid protein 2 (VP2) [285–293] was purchased from ProImmune
(Oxford, UK). Splenic CD8 T cells from naive and CVB3-infected
b5i/LMP7
+/+ and b5i/LMP7
-/- mice (d8 p.i., n=10) were stained
according to the instructions of the manufacturer (Pentamer-PE,
CD8-FITC, CD19-PE Cy5) as described recently [19]. Pentamer-
positive VP2 [285-293]-specific CD8 T cell numbers (1610e5
gated cells) did not differ between the two hosts. (B) For T cell
transfer studies splenic CD8 T cells were separated by MACS
(Miltenyi Biotec) from 1610
7 splenocytes (splenocytes taken from
CVB3-infected mice). Purity of respective CD8 T cell populations
for T cell transfer studies was .85%. Representative dot plots
indicate the amounts of CD8
+/CD3
+ T cells post-MACS.
(PDF)
Figure S3 (to Fig. 6D) Accumulation of poly-ub protein
conjugates in IP-deficient mice. Formation of ALIS was
visualized by immunofluorescence. Heart cryosections from naive
and CVB3-infected b5i/LMP7
+/+ and b5i/LMP7
-/- mice (d8 p.i.)
were stained with FK1 for poly-ub (green). Slides from four
different individual mice are shown (representative for n=6 mice
from two independent experiments).
(PDF)
Figure S4 (to Fig. 6E) Accumulation of poly-ub protein
conjugates in IP-deficient mice. To visualize poly-ubiquitin
conjugates within the injured myocardium, immunohistology
staining of ubiquitin was performed in control and CVB3-infected
mice (sacrificed at d4 and d8 p.i.). 1
st column controls: negative
controls reflect secondary antibody staining only within the
myocardium (upper panel) and within an inflammatory focus
(lower panel). Ubiquitin staining is shown for two representative
naive mice from b5i/LMP7
+/+ and b5i/LMP7
-/- mice. 2
nd
column d4 p.i. Ubiquitin staining is shown for three different
mice from each host. No specific increase in ubiquitin signals is
visualizable at this time point. 3
rd–5
th column d8 p.i. Ubiquitin
staining is illustrated for three different mice representing at least
n=5 mice / host. Three different tissue sections are shown per
mouse indicating increased poly-ub detection in CVB3-infected
b5i/LMP7
-/- mice.
(PDF)
Figure S5 (to Fig. 7) IP-deficient hearts are prone to
apoptotic cell death. Apoptosis was assessed in vivo in cardiac
tissue sections in naive and CVB3-challenged mice (d4 and d8 p.i.)
by in situ cell death detection kit, TMR red. Representative cardiac
sections from one independent experiment are shown. (A)
Controls: lower two slides illustrate DNA strand breaks within
inflammatory lesions and surrounding cardiomyocytes, which
colocalize to nuclei (last slide). (B) TUNEL staining is shown for
one control heart and four individual mice sacrificed at d4 p.i.
(representative for n=6 mice). No apoptotic cell death was
detected in these mice. (C) DNA strand breaks were visualized in
CVB3-infected hearts from b5i/LMP7
-/- mice: three representa-
tive slides are shown for each heart. Increased levels of TUNEL-
positive cells are located particularly within inflammatory lesions
and surrounding cardiomyocytes. In CVB3-infected b5i/LMP7
+/+
mice hardly any apoptotic lesions were detected (1
st row
representative for n=8 mice).
(PDF)
Figure S6 (to Fig. 7) Apoptotic cell death within inflam-
matory lesions in IP-deficient mice. To further localize
cellular injury within the injured myocardium, in situ cell death
detection kit, POD was used. Tissue sections are representative for
at least n=5 mice.
(PDF)
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